The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
Open accessAbstract
To understand how virulent mycobacteria subvert host immunity and establish disease, we examined the differential response of mice to infection with various human outbreak Mycobacterium tuberculosis clinical isolates. One clinical isolate, HN878, was found to be hypervirulent, as demonstrated by unusually early death of infected immune-competent mice, compared with infection with other clinical isolates. The differential effect on survival required lymphocyte function because severe combined immunodeficiency (SCID) mice infected with HN878 or other clinical isolates all died at the same rate. The hypervirulence of HN878 was associated with failure to induce M. tuberculosis-specific proliferation and IFN-γ production by spleen and lymph node cells from infected mice. In addition, 2- to 4-fold lower levels of tumor necrosis factor-α (TNF-α), IL-6, IL-12, and IFN-γ mRNAs were observed in lungs of HN878-infected mice. IL-10, IL-4, and IL-5 mRNA levels were not significantly elevated in lungs of HN878 infected mice. In contrast, IFN-α mRNA levels were significantly higher in lungs of these mice. To further investigate the role of Type 1 IFNs, mice infected with HN878 were treated intranasally with purified IFN-α/β. The treatment resulted in increased lung bacillary loads and even further reduced survival. These results suggest that the hypervirulence of HN878 may be due to failure of this strain to stimulate Th1 type immunity. In addition, the lack of development of Th1 immunity in response to HN878 appears to be associated with increased induction of Type 1 IFNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sturgill-Koszycki, S., Schlesinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., & Russell, D. G. (1994) · Science · doi:10.1126/science.8303277 · Cited by 1,302
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Merriam-Webster's collegiate dictionary
(2004) · Choice Reviews Online · doi:10.5860/choice.41-2515 · Cited by 1,049
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationArmstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 990
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
Variations in the NRAMP1 Gene and Susceptibility to Tuberculosis in West Africans
Bellamy, R., Ruwende, C., Corrah, T., McAdam, K. P. W. J., Whittle, H. C., & Hill, A. V. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381002 · Cited by 735
Clemens, D. L., & Horwitz, M. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.257 · Cited by 687
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
ISG15 in antiviral immunity and beyond
Perng, Y.-C., & Lenschow, D. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0020-5 · Cited by 855
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
Doyle, S. E., Vaidya, S. A., O'Connell, R., Dadgostar, H., Dempsey, P. W., Wu, T.-T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00390-4 · Cited by 844
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Self-citationGagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Watson, R. O., Bell, S. L., MacDuff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J., Vance, R. E., Stallings, C. L., Virgin, H. W., & Cox, J. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.004 · Cited by 645
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
Newton, S. M., Brent, A. J., Anderson, S., Whittaker, E., & Kampmann, B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70182-8 · Cited by 480
Manzanillo, P. S., Shiloh, M. U., Portnoy, D. A., & Cox, J. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.007 · Cited by 473
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Consequences of genomic diversity in Mycobacterium tuberculosis
Coscolla, M., & Gagneux, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.012 · Cited by 451
LÓPEZ, B., AGUILAR, D., OROZCO, H., BURGER, M., ESPITIA, C., RITACCO, V, BARRERA, L., KREMER, K., HERNANDEZ-PANDO, R., HUYGEN, K., et al. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02171.x · Cited by 449
Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.002 · Cited by 418
Stanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 432
Filliol, I., Motiwala, A. S., Cavatore, M., Qi, W., Hazbón, M. H., Bobadilla del Valle, M., Fyfe, J., García-García, L., Rastogi, N., Sola, C., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.2.759-772.2006 · Cited by 431
Boshoff, H. I. M., Reed, M. B., Barry, C. E., & Mizrahi, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00270-8 · Cited by 421
Self-citationTuberculosis Pathogenesis and Immunity
Philips, J. A., & Ernst, J. D. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132458 · Cited by 416
Innate Immune Recognition of Mycobacterium tuberculosis
Kleinnijenhuis, J., Oosting, M., Joosten, L. A. B., Netea, M. G., & Van Crevel, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/405310 · Cited by 414
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 413
ESX secretion systems: mycobacterial evolution to counter host immunity
Gröschel, M. I., Sayes, F., Simeone, R., Majlessi, L., & Brosch, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.131 · Cited by 382
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Wassermann, R., Gulen, M. F., Sala, C., Perin, S. G., Lou, Y., Rybniker, J., Schmid-Burgk, J. L., Schmidt, T., Hornung, V., Cole, S. T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.003 · Cited by 401
“This finding agrees with the literature, where a correlation between IFN-b production and the virulence ofW-Beijing strains has been established (Manca et al., 2001; 2005).”
ResultMolecular Epidemiology of Tuberculosis
Barnes, P. F., & Cave, M. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021964 · Cited by 386
Tuberculosis: a problem with persistence
Stewart, G. R., Robertson, B. D., & Young, D. B. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro749 · Cited by 386
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Self-citationThe host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360
The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion
Ehlers, S., & Schaible, U. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00411 · Cited by 342
The Roles of Type I Interferon in Bacterial Infection
Boxx, G. M., & Cheng, G. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.016 · Cited by 335
Sambandamurthy, V. K., Wang, X., Chen, B., Russell, R. G., Derrick, S., Collins, F. M., Morris, S. L., & Jacobs, W. R. (2002) · Nature Medicine · doi:10.1038/nm765 · Cited by 336
Triggers and drivers of autoimmunity: lessons from coeliac disease
Sollid, L. M., & Jabri, B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3407 · Cited by 331
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
Macrophages in tuberculosis: friend or foe
Guirado, E., Schlesinger, L. S., & Kaplan, G. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0388-2 · Cited by 306
Self-citationRole of innate cytokines in mycobacterial infection
Cooper, A. M., Mayer-Barber, K. D., & Sher, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.13 · Cited by 300
Manca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 294
Self-citationDeletion of Two-Component Regulatory Systems Increases the Virulence of Mycobacterium tuberculosis
Parish, T., Smith, D. A., Kendall, S., Casali, N., Bancroft, G. J., & Stoker, N. G. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1134-1140.2003 · Cited by 293
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Pandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292
Jin, L., Hill, K. K., Filak, H., Mogan, J., Knowles, H., Zhang, B., Perraud, A.-L., Cambier, J. C., & Lenz, L. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100088 · Cited by 288
Type I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K., Sher, A., & O’Garra, A. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 282
Gopal, R., Monin, L., Slight, S., Uche, U., Blanchard, E., A. Fallert Junecko, B., Ramos-Payan, R., Stallings, C. L., Reinhart, T. A., Kolls, J. K., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004099 · Cited by 274
Lessons from experimental Mycobacterium tuberculosis infections
Flynn, J. L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.033 · Cited by 270
Dey, B., Dey, R. J., Cheung, L. S., Pokkali, S., Guo, H., Lee, J.-H., & Bishai, W. R. (2015) · Nature Medicine · doi:10.1038/nm.3813 · Cited by 268
Tsenova, L., Ellison, E., Harbacheuski, R., Moreira, A. L., Kurepina, N., Reed, M. B., Mathema, B., Barry III, C. E., & Kaplan, G. (2005) · The Journal of Infectious Diseases · doi:10.1086/430614 · Cited by 264
Self-citationOrdway, D., Henao-Tamayo, M., Harton, M., Palanisamy, G., Troudt, J., Shanley, C., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 259
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00734-z · Cited by 255
Rao, V., Fujiwara, N., Porcelli, S. A., & Glickman, M. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041668 · Cited by 238
Moreira-Teixeira, L., Tabone, O., Graham, C. M., Singhania, A., Stavropoulos, E., Redford, P. S., Chakravarty, P., Priestnall, S. L., Suarez-Bonnet, A., Herbert, E., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0610-z · Cited by 127
Patrick, K. L., Bell, S. L., Weindel, C. G., & Watson, R. O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00138 · Cited by 110
Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship
Briken, V., Ahlbrand, S. E., & Shah, S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00062 · Cited by 92
Interfering with immunity: detrimental role of type I IFNs during infection
Stifter, S. A., & Feng, C. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402794 · Cited by 78
Rovetta, A. I., Peña, D., Hernández Del Pino, R. E., Recalde, G. M., Pellegrini, J., Bigi, F., Musella, R. M., Palmero, D. J., Gutierrez, M., Colombo, M. I., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.981791 · Cited by 71
Metadata
- Authors
- Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-04-24
- Volume
- 98
- Issue
- 10
- Pages
- 5752-5757
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2065217848
- Cited by
- 595
- References
- 32
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.